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Abstract Using the dextran-binding domain (DBD) of a type of
glucosyltransferase (GTF) from Streptococcus sobrinus, we have
developed a novel method for purifying recombinant proteins.
DBD-tagged green and red fluorescent proteins as well as the
parent GTF and DBD moiety were adsorbed well to commer-
cially available cross-linked dextran (such as Sephadex beads
and Sephacryl beads), and eluted efficiently with water-soluble
dextran. The purity of the eluted proteins after this one-step
affinity purification was V90% or better. The results suggest
that DBD can be used as a powerful carrier for purification of
various recombinant proteins. ß 2001 Published by Elsevier
Science B.V. on behalf of the Federation of European Biochem-
ical Societies.
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1. Introduction
Thanks to the development of genetic engineering tech-
niques, it is now possible to prepare a protein of interest as
a recombinant protein relatively easily, rapidly, and reprodu-
cibly, in host cells such as Escherichia coli, yeast, baculovirus,
or mammalian cells. One of the most powerful techniques is
the use of carrier sequences. The carrier sequences are fused to
the proteins of interest as a ‘tag’, to be used for their puri¢-
cation, immobilization, immunological detection, localization
study in vivo, and screening of the proteins that interact with
the target proteins [1^6].
There are several advantages to each of the existing tag
systems, such as a maltose-binding protein (MBP), gluta-
thione-S-transferase (GST), or consecutive histidine residues.
However, some target proteins are di⁄cult to obtain using
these tags, due to inhibited expression of the fusion protein
or formation of insoluble aggregate. In some cases, the trou-
ble can be avoided by utilization of a di¡erent tag. Therefore,
in order to prepare various proteins e⁄ciently, it is advanta-
geous to have a large variety of tag systems.
The dextran-binding domain (DBD) is a functional moiety
of glucosyltransferase (GTF) from oral streptococci (see Fig.
1a). DBD is known to interact with dextran reversibly [7^10].
The DBD-binding unit of a single dextran chain consists of
approximately 15 glucosyl residues, and the binding constant
to the unit (2U105 M31) is relatively low. However, insoluble,
cross-linked dextrans such as Sephadex beads or Sephacryl
beads have multiple binding sites for DBD. As a result,
DBD binds to these beads almost irreversibly in the absence
of water-soluble dextran. In fact, in our recent work [10],
speci¢c and irreversible interaction between £uorescently la-
beled GTF and Sephadex G-100 was directly imaged under a
£uorescence microscope. Adsorbed GTF molecules were
easily eluted from the beads with water-soluble dextran in
excess. Moreover, GTF from oral bacteria, Streptococcus so-
brinus 6715, was puri¢ed by binding to insoluble dextrans
followed by elution using soluble dextran or denaturing sol-
vents such as guanidine hydrochloride [11,12]. These observa-
tions suggest the possibility of collecting recombinant proteins
fused to DBD speci¢cally from the cell lysates, and eluting
them by addition of water-soluble dextran.
In the present work, we demonstrate that the DBD-tag is in
fact a powerful tool for rapid puri¢cation of target proteins.
We characterized some features of the DBD-tag system for its
e⁄cient use. One of the advantages of the DBD puri¢cation
method is its low cost compared with other tag systems, be-
cause expensive resins are not required. Also, dextran is an
inactive molecule so that it has little e¡ect on the functions of
the target proteins.
2. Materials and methods
2.1. Chemicals
Dextrans of di¡erent sizes were purchased from the following sour-
ces: dextran (18.1 kDa, industrial grade), from Sigma; dextran T-10,
T-500, and T-2000 (10, 500, and 2000 kDa, respectively), for enzy-
matic studies, from Pharmacia; dextran (5^150 kDa, for gel-¢ltration
analysis), from Fluka; and dextran (4000^5000 kDa, for molecular
weight standard), from Polyscience. Sephadex G-200, Sephadex G-100
(Super¢ne), Sephadex G-25 (Fine), and Sephacryl S-500 HR were
from Pharmacia. All cross-linked dextrans were well soaked in bu¡er
before use. Other reagents were of analytical grade.
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2.2. Plasmid construction
To obtain DBD consisting of 3.5 repetitive units (referred as A
repeats, [13]), the plasmid that encodes GTF I of S. sobrinus 6715
(pAB2) was digested by HindIII as described by Abo et al. [8]. The
resultant fragment was ligated into the HindIII site of the pUC 18
vector, which is in phase with the lacZ reading frame. Here we refer to
this plasmid as ‘pDBD’. DNA fragments encoding a green £uorescent
protein (GFP) and a red £uorescent protein (RFP) were subcloned
into the BamHI site of pDBD using 5P BglII and 3P BamHI restriction
sites engineered by a polymerase chain reaction to obtain pGFP^DBD
and pRFP^DBD. The gene products of pGFP^DBD and pRFP^
DBD are referred as GFP^DBD and RFP^DBD, respectively.
2.3. Protein expression and puri¢cation
The proteins were expressed in E. coli BL21(DE3) cells freshly
transformed with the plasmids, pAB2, pDBD, pGFP^DBD, and
pRFP^DBD. Overnight cultures of bacteria were diluted 1:200 in
TPM medium [14] supplemented with ampicillin (100 Wg/ml), and
grown with shaking at 37‡C until the absorbance at 600 nm reached
0.4. The cells were shaken for another 15 min at 20‡C before induc-
tion with isopropyl L-D-thiogalactopyranoside (0.5 mM). After incu-
bation for 4 h at 20‡C, the cells were harvested by centrifugation
(2 min at 2000Ug), and washed with bu¡er A (10 mM Tris-acetate
(pH 8.0), 1 mM magnesium acetate, and 250 mM potassium acetate).
The bacterial pellets were re-suspended in bu¡er A supplemented with
protease inhibitors (1 mM phenylmethylsulfonyl £uoride, 1 Wg/ml leu-
peptin, 1 Wg/ml pepstatin, 10 Wg/ml Na-p-tosyl-L-arginine methyl ester,
and 1.0 Wg/ml aprotinin), disrupted by sonication, and then centri-
fuged (30 000Ug, 30 min, 4‡C). 1/20 volume of a 50% (v/v) slurry of
Sephadex G-100 beads was added to the supernatant, and mixed
gently for 2 h at 4‡C. The beads were then collected by brief centri-
fugation (30 s at 500Ug), and washed four times with 30 volumes of
bu¡er A. Finally, the proteins were eluted by applying an equal vol-
ume of 50 mg/ml dextran (18.1 kDa) to the beads, and analyzed by
SDS^PAGE/Coomassie brilliant blue staining.
It has been shown that GTF can be puri¢ed from oral streptococci
using dextran beads [11,12]. We con¢rmed the results in our recombi-
nant puri¢cation system as above, and also checked to see if DBD is
also puri¢ed e⁄ciently using the same method. GTF and DBD were
only 1^3% of the total proteins in the soluble fractions of the bacterial
cell extract (Fig. 1b, lanes 1 and 3). After the puri¢cation step using
Sephadex G-100 beads, both GTF and DBD appeared as single bands
on SDS^PAGE/Coomassie brilliant blue staining (Fig. 1b, lanes 2 and
4), suggesting high feasibility of this system for purifying various
DBD-tagged proteins.
2.4. The binding capacities of cross-linked dextrans for DBD-fusion
proteins
The binding capacities of cross-linked dextrans beads were exam-
ined for GTF and DBD, and for GFP^DBD in cell extract. GTF or
DBD was puri¢ed in advance by the method described previously [9].
Proteins (0.5 mg/ml) were incubated with 0.75^5% (v/v) cross-linked
dextran beads (Sephadex G-100, G-200, G-25, or Sephacryl S-500
HR) in bu¡er A, with gentle mixing for 3 h at 25‡C. After sediment-
ing the beads (30 s at 500Ug), the concentration of the protein in the
supernatant was determined by the Bradford method [15] to calculate
the amount of GTF and DBD adsorbed to the dextran beads.
In order to examine the binding capacity in an actual puri¢cation
procedure, cell extract containing GFP^DBD was used. After high
speed centrifugation of the extract, 1/25 volume of Sephadex G-100
beads were added to the supernatant, incubated for 2 h at 4‡C, and
then sedimented by centrifugation (30 s at 500Ug). The concentration
of GFP^DBD in the supernatant was directly determined by optical
measurement (OD488).
2.5. E⁄ciency of elution of DBD-fusion proteins from cross-linked
dextran beads
Crude cell extract was incubated with Sephadex G-100 beads as
above to adsorb expressed GFP^DBD to the beads. After the beads
were washed with bu¡er A, a part of the beads solution was analyzed
by SDS^PAGE. The amount of GFP^DBD adsorbed to the beads
was estimated by densitometry of the Coomassie brilliant blue-stained
gel. The protein was eluted by addition of an equal volume of water-
soluble dextran to the beads solution. After centrifugation (30 s at
500Ug), the amount of the recovered protein was determined by mea-
suring the concentration of GFP^DBD in the supernatant.
To examine how the amount of the eluted protein depends on the
concentration of dextran, 0^50 mg/ml (at a ¢nal concentration)
dextran (18.1 kDa) was used. To investigate the size dependency,
dextrans with the relative molecular mass of 1^5000 kDa (at a ¢nal
concentration of 30 mg/ml) were examined.
3. Results and discussion
3.1. Puri¢cation of DBD-tagged fusion proteins
As described in Section 2.3, recombinant GTF and DBD
expressed in E. coli BL21 (DE3) cells were obtained with the
purity better than 95% by the one-step a⁄nity puri¢cation. In
order to check whether DBD can be generally used as a tag
for purifying recombinant proteins, we used crude cell extract
containing two constructs, GFP^DBD and RFP^DBD, as test
specimens. Both DBD-tagged proteins were puri¢ed by the
batch processing as above. As shown in Fig. 1b (lanes 5^8),
these proteins were also puri¢ed to the level of 89% (for GFP^
DBD) and 92% (for RFP^DBD). Similar results were ob-
tained using Sephadex G-200 and Sephacryl S-500 HR (data
not shown). These results strongly suggest that the DBD^dex-
tran beads system is a powerful tool for puri¢cation of vari-
ous recombinant proteins.
3.2. Estimation of the binding capacities of cross-linked
dextrans for DBD-fusion proteins
In order to perform the puri¢cation procedure e⁄ciently,
Fig. 1. One-step puri¢cation of recombinant proteins using DBD as
the tag. Schematic representation of the recombinant proteins (a)
and SDS^PAGE analysis of the protein preparations (b). The calcu-
lated molecular weight of each protein is indicated in parentheses.
The parent GTF (lanes 1 and 2), its functional moiety DBD (lanes
3 and 4), the DBD-tagged proteins GFP^DBD (lanes 5 and 6) and
RFP^DBD (lanes 7 and 8) were adsorbed with Sephadex G-100
beads and eluted with 25 mg/ml dextran (18.1 kDa). The SDS^
PAGE patterns of the proteins before (lanes 1,3,5 and 7) and after
(lanes 2,4,6 and 8) this one-step puri¢cation step are shown. After
the puri¢cation, the SDS gel shows mainly single strong bands ap-
proximately corresponding to the expected molecular weights. The
purity of those proteins were 95%, 96%, 89%, and 92% for GTF,
DBD, GFP^DBD, and RFP^DBD, respectively.
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we quantitatively estimated the amount of DBD-tagged pro-
teins bound to the dextran beads. First, the maximum binding
capacities were studied using puri¢ed proteins, GTF and
DBD, which were obtained by established methods [9].
When incubated with Sephadex G-200 beads at di¡erent con-
centrations, the amount of GTF (Fig. 2, open circles) or DBD
(Fig. 2, closed diamonds) adsorbed to the beads was propor-
tional to the volume of the added beads. The binding capaci-
ties of Sephadex G-200 calculated from the graph were 3 mg
protein/ml beads for DBD, and 14 mg of protein/ml beads for
GTF. Considering the molecular weight of DBD (30 kDa)
and GTF (138 kDa), these two proteins were adsorbed to
Sephadex G-200 at nearly the same molar levels (V100
Wmol protein/ml beads). The binding capacity determined
here is as good as or better than obtained with the histi-
dine-tag or GST-tag methods [16,17].
Sephadex G-100 and Sephacryl S-500 HR beads also
showed high binding capacities, especially for DBD: the bind-
ing capacities of Sephadex G-100 were 11 and 17 mg protein/
ml beads for DBD and GTF, respectively, and those of Se-
phacryl S-500 HR were 14 and 5 mg protein/ml beads for
DBD and GTF, respectively. In contrast, Sephadex G-25
beads that have a smaller pore size (fractionation range for
globular proteins in gel-¢ltration: 1U103^5U103) did not re-
tain either GTF or DBD at all. This is probably because
DBD-tagged recombinant proteins can bind in the pore of
the dextran beads only if the pore is su⁄ciently large. Since
Sephadex G-100, G-200, and Sephacryl S-500 HR all showed
high binding capacities for puri¢ed GTF and DBD, we used
Sephadex G-100 for the following experiments.
The results in Fig. 1 showed that DBD-tagged GFP and
RFP were collected e⁄ciently from the cell extract by dextran
beads, even though the original extract contained only a few
percent of the DBD-tagged proteins. Using Sephadex G-100,
we determined the fraction of GFP^DBD adsorbed to the
beads. More than 30% of the soluble GFP^DBD was col-
lected by incubation with 1/25 volume of Sephadex G-100
beads in bu¡er A at 4‡C for 2 h (5 mg of GFP^DBD/ml of
beads). The fraction was increased to 70% when the incuba-
tion time was extended to 15 h.
Proteins are often puri¢ed in the presence of bio-active
reagents, to preserve the functions of the target proteins. Since
some of these reagents might interfere with the interaction
between DBD and dextran beads, various reagents were
added to the control solution (10 mM Tris-acetate (pH 8.0)
alone), and the amount of GFP^DBD adsorbed to the beads
was compared with the control. Tested chemical reagents and
the relative amount of the adsorbed GFP^DBD were: 100 mM
NaCl (115%), 100 mM Imidazole (123%), 2 mM EGTA
(135%), 2 mM CaCl2 (106%), 2 mM EDTA (139%), 2 mM
MgCl2 (124%), 0.05% 2-mercaptoethanol (118%), 1 mM DTT
(124%), 0.5% polyoxyethylene (10) octylphenyl ester (Triton
X-100) (137%), 0.1% polyoxyethylenesorbitan monolaurate
(Tween 20, 82%), 0.05% NaN3 (135%), and 1 mM ATP
(123%). Therefore, the resultant binding capacities were with-
in 80^140% of the control, indicating that these reagents do
not largely a¡ect the capacity. We have also examined the
e¡ect of the ionic strength: when 0 to 0.5 M NaCl was added
Fig. 2. The binding capacity of Sephadex G-200 for DBD contain-
ing proteins. A Sephadex G-200 solution was mixed with an excess
amount of puri¢ed GTF or DBD (0.5 mg/ml) in bu¡er A, and cen-
trifuged as described in Section 2.4. The amount of GTF and DBD
adsorbed to the dextran beads was estimated by measuring the con-
centration of the protein in the supernatant. The adsorbed GTF
(open circles) and DBD (closed diamonds) increased linearly with
the volume of the added beads. 1 ml of beads has the capacity to
adsorb 14 mg GTF or 3 mg DBD.
Fig. 3. E¡ect of the concentration of dextran for the elution step.
The soluble fraction containing GFP^DBD was mixed with Sepha-
dex G-100, and the protein was eluted by the addition of water-
soluble dextran (18.1 kDa) to the ¢nal concentrations of 0^50 mg/
ml, and the concentration of the eluate was measured by the optical
method. The amount of eluted GFP^DBD was nearly maximal with
30 mg/ml dextran.
Fig. 4. Dependency of the elution e⁄ciency on the size of dextran.
After incubation with Sephadex G-100, GFP^DBD was eluted with
water-soluble dextrans of various sizes. The percentages of the re-
covered protein are shown. Dextrans with a size of 5^70 kDa
showed high e⁄ciency.
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to the control solution, the fraction of the adsorbed protein
increased dose-dependently from 23% to 33% (data not
shown).
3.3. Estimation of the elution e⁄ciency of DBD-fusion protein
from cross-linked dextran
DBD-tagged proteins bound to dextran beads were eluted
using water-soluble dextran. We ¢rst estimated the optimum
concentration of water-soluble dextran that is used for elu-
tion. After speci¢c binding to Sephadex beads and extensive
washing with bu¡er A, GFP^DBD was eluted with an equal
volume of water-soluble dextran (18.1 kDa) at various con-
centrations. As shown in Fig. 3, the amount of the protein in
the supernatant increased dose-dependently, and reached a
plateau when the concentration of dextran was approximately
30 mg/ml.
Using 50 mg/ml dextran, 43% of the protein adsorbed to
the beads was recovered. When the elution procedure was
repeated, 31% was subsequently recovered with the second
elution, and 17% with the third. Thus, almost all (91% in
total) of the adsorbed protein was recovered by the three-
step elution with 50 mg/ml dextran.
We then examined how the elution e⁄ciency depends on
the size of the water-soluble dextran. Fig. 4 shows that GFP^
DBD was e⁄ciently eluted with 5 to 70 kDa dextrans, but
poorly eluted with smaller (1 kDa) or larger (s 150 kDa)
dextrans. As described in Section 3.2, it is likely that DBD-
tagged proteins bind in the pore of the beads. Thus, to elute
the bound protein e⁄ciently, water-soluble dextran would
have to enter the pore of the beads, and then bind tightly
to DBD. Since the Sephadex G-100 beads used here is known
to be suitable for separation of 1^100 kDa water-soluble dex-
tran, it is expected that dextran with larger sizes can not enter
the pore. Smaller dextran, on the other hand, would enter the
pore but have only a weak a⁄nity to DBD. In fact, our
calorimetric experiments showed that the a⁄nity of DBD to
dextran remained unchanged when the molecular weight of
the dextran was higher than 10 kDa, but decreased when it
was lower than 5 kDa (Kaseda, K. and Kodama, T., unpub-
lished data). These results indicate that the optimum size of
water-soluble dextran for the elution step is 5^70 kDa, when
Sephadex G-100 is used to collect DBD-tagged proteins.
3.4. Evaluation of the DBD puri¢cation method
The DBD-fusion method described here permits one-step
puri¢cation of recombinant proteins from crude cellular ly-
sates. This method has several advantages. Firstly, the cost
of the puri¢cation procedure is lower than with most of other
methods, since expensive resin modi¢ed with speci¢c ligand is
not needed. Secondly, because dextran is an inactive molecule,
it does not necessarily have to be removed after the elution
steps. This means that the time required for puri¢cation could
be shortened. Another advantage is that DBD refolds easily
after being denatured with chemicals including guanidine hy-
drochloride, urea, SDS, and by heating. Thus, even if proteins
with DBD aggregate with each other to form an insoluble
inclusion body, they can be recovered after solubilization
with a denaturing agent. Additionally, DBD has no cysteinyl
residue, so that we can speci¢cally modify cysteine residues in
the target protein with some thiol-reactive probes for func-
tional and/or structural studies. Finally, it has been shown
that DBD is still functional when truncated at the C-terminus
to 25 kDa [8]. The minimum functional DBD is not known
yet, but it is possible that a smaller domain of DBD can be
used as a tag for purifying recombinant proteins.
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